A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing
Clinical trial NCT01749306 · TERMINATED
Trial details
- NCT number
- NCT01749306
- Sponsor
- Shire Regenerative Medicine, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-11-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.